Second, it, as a TP53 variant in a Chinese population, protects breast cancer, the most frequent LFS tumor type and increases the risk for soft-tissue sarcoma, the second most frequent LFS tumor type. This evidence concerns the gene TP53 and soft tissue sarcoma.